Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy
1998

Electrochemotherapy for Skin Tumors

Sample size: 50 publication Evidence: high

Author Information

Author(s): LM Mir, LF Glass, G Sersa, J Teissi, C Domenge, D Miklavdic, MJ Jaroszeski, S Orlowski, DS Reintgen, Z Rudolf, M Belehradek, R Gilbert, M-P Rols, J Belehradek Jr, JM Bachaud, R DeConti, B Stabuc, M Cemazar, P Coninx, R Heller

Hypothesis

The study aims to demonstrate the anti-tumour effectiveness of electrochemotherapy (ECT) with bleomycin on cutaneous and subcutaneous tumours.

Conclusion

Electrochemotherapy was shown to be an effective local treatment for various types of skin tumors with minimal side effects.

Supporting Evidence

  • 85.3% of evaluable tumors showed objective responses.
  • 56.4% of tumors achieved complete responses.
  • Minimal adverse side effects were observed.
  • ECT was effective regardless of tumor histology.
  • Patients reported tolerable pain during the procedure.

Takeaway

Doctors used electricity to help a special medicine get into cancer cells, and it worked really well for many patients with skin tumors.

Methodology

Patients with various skin tumors received bleomycin followed by electric pulses to enhance drug delivery, and their responses were evaluated after treatment.

Potential Biases

Potential bias due to the non-randomized nature of the trials and the involvement of multiple centers.

Limitations

The study included a limited number of patients and specific tumor types, which may affect the generalizability of the results.

Participant Demographics

Patients included 10 with basal cell carcinoma, 20 with malignant melanoma, 3 with adenocarcinoma, and 17 with head and neck squamous cell carcinoma.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication